Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Read user reviews to learn about the best cashback credit cards that don’t charge fees. Make an informed choice!
22,713 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A growing wave of retirees is trimming both living space and investment heft to align wealth with shifting priorities...
Tesla's Q2 delivery figures offer a clear window into demand trends and pricing power. This guide breaks down what to...
A growing share of retirees with roughly $700k saved in a 401(K) face higher Social Security taxes because the income...
A 64-year-old with $1.5 million in retirement assets faces a costly year before Medicare, as ACA premiums and uncover...
Real estate professionals push back at NAR's trademark enforcement drive during midyear meetings, arguing it diverts ...
As Nasdaq income options proliferate, investors weigh tax treatment and true take-home yields. A clear, current compa...
More than 200 economists, including 16 Nobel laureates, sign a call admitting they lack clarity on AI's economic effe...
Sam Altman raised questions about SpaceX's bold plan for AI data centers in space. This article breaks down the viabi...
Palantir faces a pivotal investor update that could move the stock. This guide breaks down the risks, catalysts, and ...
A major fund recently disclosed a large move in Globalstar as the stock surged. This article explains what happened, ...
A mid‑sized fund just boosted its stake in ServiceTitan after a sharp share drop. This article unpacks what the move ...